Shionogi, JP3347200002

Jefferies sets JPY 3,900.00 target for Shionogi stock

Published on 10/15/2026 at 22:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal first-quarter revenue was JPY 163.31 billion. Shionogi stock costs EUR 16.53 on October 15, 2026, up 3.76 percent on Tokyo Stock Exchange.

Analyst target and operating scale

Jefferies set a JPY 3,900.00 target for Shionogi on October 12, 2026.
Fiscal first-quarter revenue reached JPY 163.31 billion for the period ended June 30, 2026.
Shionogi stock costs EUR 16.53 at Lang & Schwarz on October 15, 2026, up 3.76 percent on the Tokyo Stock Exchange.
Shionogi traded at a 9.35 P/E ratio with a JPY 2.5 trillion market capitalization on October 15, 2026.

Shionogi, JP3347200002, Illustration mit AI erstellt.

Jefferies maintained a Buy rating on Shionogi and set a JPY 3,900.00 price target on October 12, 2026, leaving the target 34.72 percent above the Tokyo-listed price of JPY 2,895.00. Markets Insider reported the analyst action. Fiscal first-quarter revenue reached JPY 163.31 billion for the period ended June 30, 2026, versus JPY 99.78 billion a year earlier, according to JPX Market Explorer. Shionogi stock was trading at EUR 16.53 at Lang & Schwarz on October 15, 2026 at 9:50 p.m. CEST, up 3.76 percent on the Tokyo Stock Exchange versus its prior close.

Revenue sets the operating scale

The first-quarter revenue comparison is the clearest fundamental marker in the current picture. Shionogi reported JPY 163.31 billion against JPY 99.78 billion a year earlier, a 63.67 percent increase. Net income was JPY 97.70 billion, compared with JPY 39.36 billion in the year-ago quarter, while diluted earnings per share reached JPY 114.78 against JPY 46.25.

Stock sits below its yearly high

The Tokyo price of JPY 2,895.00 on October 15, 2026 stood 22.96 percent below the 52-week high of JPY 3,758.00 and 21.00 percent above the low of JPY 2,392.50. Trading volume was 6,215,800 shares, against an average of 2,823,640 shares. The move therefore came with volume 120.16 percent above the average.

Valuation and peer comparison

Shionogi's market capitalization was JPY 2.5 trillion on October 15, 2026, and its P/E ratio was 9.35. Astellas Pharma and Daiichi Sankyo provide a useful same-market comparison.

Comparison with peers

Shionogi (Tokyo Stock Exchange, JPY): plus 3.76 percent, P/E 9.35, market capitalization JPY 2.5 trillion

Astellas Pharma (Tokyo Stock Exchange, JPY): plus 4.15 percent, P/E 11.60, market capitalization JPY 4.2 trillion

Daiichi Sankyo (Tokyo Stock Exchange, JPY): plus 1.92 percent, P/E 20.08, market capitalization JPY 4.8 trillion

What the target implies

The JPY 3,900.00 target sits above both the October 15 price and Shionogi's 52-week high. That gap makes the analyst view a valuation reference rather than a forecast from the company. The investor calendar also includes the planned November to December 2026 completion window for the IntraBio transaction, which was announced on October 5, 2026.

Price remains the daily anchor

For German investors, the euro quote offers the clearest live market reference after the Xetra session. Shionogi stock was trading at EUR 16.53 at Lang & Schwarz on October 15, 2026 at 9:50 p.m. CEST, up 3.76 percent on the Tokyo Stock Exchange versus its prior close. The further course of trading is shown by the continuously updated real-time quote of Shionogi stock.